Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY 2024. That’s a compound annual growth rate ...

Merck leads U.S. pharma in 2025, but faces Keytruda patent loss by 2028. Click for my look at MRK stock ahead of its upcoming ...

Merck & Co., Inc. (NYSE:MRK) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Merck & Co., Inc.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House ...

Merck KGaA, a German integrated science, pharmaceutical, and technology company with a significant market presence in the U.S ...

The Trump administration struck a deal with EMD Serono, the health care business of Merck KGaA in the United States and ...

Johnson & Johnson ranks highest in Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.

The massive AI deals and capital spending plans announced by some of the top technology companies have stunned many on Wall ...

U.S. President Donald Trump and Germany’s Merck KGaA announced a deal to sharply cut the price of key IVF drugs in the United ...

In a report released today, Geoff Meacham from Citi resumed coverage with a Hold rating on Merck & Company and a price target of $95.00. The company’s shares closed last Friday at $85.99. Take ...